MedTrace Logo

Medicine Adherence and Effects on Transplants With Pilloxa's Electronic Pillbox

NCT03848585 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2021-09-23

No results posted yet for this study

Summary

Poor adherence to medication among patients with chronic diseases is a major problem. A patient group where the adherence to prescribed medications is extremely important are organ transplanted patients. It is well established that lack of adherence to immunosuppressive medication drastically increases the risk of rejection reactions, graft loss and deaths.

Pilloxa is a device meant to help users manage medication and support adherence to medication. This study evaluates if Pilloxa improves adherence to treatment for transplanted patient compared with conventional management. Patients who have received a transplanted kidney or liver will be studied.

Pilloxa is a system comprising of: a box with 14 separate containers to temporarily store tablets/capsules in and that can be open by 14 independent lids, a smartphone application and cloud based servers. The pillbox will at given times detect if pills are present in the different compartments and can connect, send and receive information to/from mobile application and the cloud.

Conditions

  • Kidney Transplant; Complications
  • Liver Transplant; Complications

Interventions

DEVICE

Pilloxa Pillbox

A Pilloxa Pillbox is used for the prescribed immunosuppressants.

OTHER

Non active Pilloxa Pillbox

A Pilloxa Pillbox with reminders disabled and without active mobile application is used for the prescribed immunosuppressants.

Sponsors & Collaborators

  • Pilloxa

    lead INDUSTRY

Principal Investigators

  • Gunnar Söderdahl, MD, PhD · Karolinska University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-29
Primary Completion
2020-10-12
Completion
2020-10-12

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03848585 on ClinicalTrials.gov